168 related articles for article (PubMed ID: 31621996)
1. G-Quadruplex-Binding Small Molecule Induces Synthetic Lethality in Breast Cancer Cells by Inhibiting c-MYC and BCL2 Expression.
Paul R; Das T; Debnath M; Chauhan A; Dash J
Chembiochem; 2020 Apr; 21(7):963-970. PubMed ID: 31621996
[TBL] [Abstract][Full Text] [Related]
2. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
3. Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia.
Hu MH; Yu BY; Wang X; Jin G
Bioorg Chem; 2020 Nov; 104():104264. PubMed ID: 32920366
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.
Shan C; Yan JW; Wang YQ; Che T; Huang ZL; Chen AC; Yao PF; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
J Med Chem; 2017 Feb; 60(4):1292-1308. PubMed ID: 28128954
[TBL] [Abstract][Full Text] [Related]
8. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
9. Curcumin analogs exhibit anti-cancer activity by selectively targeting G-quadruplex forming c-myc promoter sequence.
Pandya N; Khan E; Jain N; Satham L; Singh R; Makde RD; Mishra A; Kumar A
Biochimie; 2021 Jan; 180():205-221. PubMed ID: 33188859
[TBL] [Abstract][Full Text] [Related]
10. Human Telomeric G-Quadruplex Selective Fluoro-Isoquinolines Induce Apoptosis in Cancer Cells.
Maiti S; Saha P; Das T; Bessi I; Schwalbe H; Dash J
Bioconjug Chem; 2018 Apr; 29(4):1141-1154. PubMed ID: 29433312
[TBL] [Abstract][Full Text] [Related]
11. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Hu MH; Lin JH
J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
[TBL] [Abstract][Full Text] [Related]
12. Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives.
Chauhan A; Paladhi S; Debnath M; Dash J
Org Biomol Chem; 2016 Jun; 14(24):5761-7. PubMed ID: 26963597
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth.
Kendrick S; Muranyi A; Gokhale V; Hurley LH; Rimsza LM
J Med Chem; 2017 Aug; 60(15):6587-6597. PubMed ID: 28605593
[TBL] [Abstract][Full Text] [Related]
14. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription.
Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988
[TBL] [Abstract][Full Text] [Related]
15. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
16. A small molecule peptidomimetic that binds to c-KIT1 G-quadruplex and exhibits antiproliferative properties in cancer cells.
Chauhan A; Paladhi S; Debnath M; Mandal S; Das RN; Bhowmik S; Dash J
Bioorg Med Chem; 2014 Aug; 22(16):4422-9. PubMed ID: 24961873
[TBL] [Abstract][Full Text] [Related]
17. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions.
Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S
Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286
[TBL] [Abstract][Full Text] [Related]
18. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
19. Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD.
Shalaby T; von Bueren AO; Hürlimann ML; Fiaschetti G; Castelletti D; Masayuki T; Nagasawa K; Arcaro A; Jelesarov I; Shin-ya K; Grotzer M
Mol Cancer Ther; 2010 Jan; 9(1):167-79. PubMed ID: 20053783
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
Harikrishna S; Kotaru S; Pradeepkumar PI
Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
